IGFBP2 and prostate carcinoma: The overexpression of IGFBP2 also correlates with the aggressiveness of some tumors, including prostate cancer, hepatoblastoma and glioma [10,17,18], suggesting that IGFBP2 possesses a carcinogenic property.